INmune Bio Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
In the following press release company mentioned the usage of animals for drug testing.
“Current therapies attempt to treat the breast cancer without eliminating the resistance mechanism. In animal models, INB03, by neutralizing the soluble TNF that drives MUC4 expression, makes the resistant cancer cells sensitive to trastuzumab. We plan to confirm this observation in the Phase II clinical trial in women with metastatic HER2+ breast cancer.” Read the full article
Company Website: https://inmunebio.com